Press Release

Robot-assisted Endoscope Market to Grow with a CAGR of 7.78% through 2028

The rising prevalence of chronic diseases and patient demand for minimally invasive procedures is expected to drive the Global Robot-assisted Endoscope Market growth in the forecast period, 2024-2028.

According to TechSci Research report, “Robot-assisted Endoscope Market – Global Industry Size, Share, Trends, Competition Forecast & Opportunities, 2028”, the Global Robot-assisted Endoscope Market stood at USD 1.19 billion in 2022 and is anticipated to grow with a CAGR of 7.78% in the forecast period, 2024-2028. This can be attributed to the rising prevalence of chronic diseases. The global increase in the prevalence of chronic diseases, such as cancer and gastrointestinal disorders, has been a significant driver of growth in the robot-assisted endoscope market. These conditions often require regular and precise monitoring, early diagnosis, and minimally invasive treatments. Robot-assisted endoscopy offers a highly effective means of managing and treating such diseases, which has led to an upsurge in demand for these systems.

Moreover, as the benefits of robot-assisted endoscopy become increasingly recognized, we can anticipate its expansion into regions that have historically lacked access to advanced medical technologies. The globalization of this market will bridge healthcare disparities and offer patients around the world access to state-of-the-art medical procedures.

                                                                                             

Browse over XX market data Figures spread through XX Pages and an in-depth TOC on "Global Robot-assisted Endoscope Market

 

The market is experiencing significant growth due to the rising prevalence of chronic illnesses such as pancreatic cancer, inflammatory bowel disease, and gastroesophageal reflux disease (GERD) across various age groups, largely stemming from unhealthy lifestyles. For example, in February 2021, the International Foundation for Gastrointestinal Disorders (IFFGD) reported that between 10% and 15% of the global population was affected by irritable bowel syndrome (IBS) at that time. According to reports published by the Centers for Disease Control and Prevention in April 2022, 3.1 million elderly individuals in the United States were dealing with IBS. Robotic endoscopy has proven to be a safe and effective tool, enhancing clinical and surgical outcomes for patients with inflammatory bowel disease (IBD). The benefits of robotic endoscopy in diagnosing conditions like irritable bowel syndrome and inflammatory bowel syndrome are expected to drive demand and accelerate market growth.

Furthermore, increased investments in the technological advancement of endoscopic visualization systems by various market participants are anticipated to fuel market expansion over the projected period. For instance, in September 2022, Virtuoso Surgical committed twenty million dollars in funding for the development of endoscopic surgery robots, covering a range of surgeries including endoscopic neurosurgery, uterine fibroids, enlarged prostates, bladder cancer, and central airway blockage removal.

However, it's important to note that the market's growth may face constraints in the projected timeframe due to the relatively high cost of surgical endoscopic procedures, challenging payment structures, and stringent regulatory reforms. The market for robotic endoscopic devices experienced significant setbacks during the COVID-19 pandemic. Global lockdowns severely impacted the diagnostics and imaging sector, leading to reduced public mobility. Non-urgent diagnostic procedures and screening programs were postponed, alleviating pressure on the healthcare system. For example, by January 2021, the COVID-19 pandemic had caused a backlog of approximately half a million endoscopic procedures necessary for the detection of gastrointestinal tumors and disorders, as reported by University College London in March 2021. In the UK, more than 90% fewer endoscopies were performed during the lockdown. The severe lockdown measures resulted in a substantial reduction in endoscopic procedures, significantly affecting market expansion.

Nevertheless, as lockdowns eased in most countries, both robotic and traditional endoscopic procedures gained momentum. Furthermore, regulatory approvals for various robotic endoscopic platforms are driving market growth. In May 2022, the U.S. FDA granted 510(k) clearance to Auris Health, Inc., an affiliate of Johnson & Johnson MedTech company Ethicon, Inc., for use in endourological treatments. This clearance allowed MONARCH to become the first and only multispecialty, adaptable robotic device suitable for bronchoscopy and urology procedures. Its purpose is to facilitate urologists' precise and safe access to specific regions of the kidney.

The Global Robot-assisted Endoscope Market is segmented into end-use, regional distribution, and company.

Based on its end-use, the outpatient facilities sector held a dominant position in the market during 2022. This sector comprises day surgery clinics and ambulatory surgery centers (ASCs), which have increasingly incorporated robot-assisted endoscopes into their medical procedures. Outpatient facilities are committed to providing patients with convenient and efficient healthcare. They prioritize minimally invasive procedures whenever feasible in order to align with the overarching objective of achieving less invasive diagnostic and treatment alternatives through the use of robot-assisted endoscopes.

Robot-assisted endoscopes are particularly attractive for outpatient environments because they frequently result in shorter recovery and surgery times. Moreover, this segment is projected to experience the highest CAGR from 2023 to 2030. Robot-assisted endoscopes can help reduce the need for more complex surgical procedures and shorten hospital stays, thereby offering a cost-effective solution for outpatient facilities. Given the increasing prevalence of gastrointestinal disorders and other conditions requiring endoscopic procedures, outpatient facilities are likely to experience growing demand for such treatments. Robotic endoscopes are well-suited to effectively meet this rising demand.

Based on region, the North American region asserted its dominance in the global market. This was facilitated by several key factors: the well-established healthcare industry, the financial capacity of hospitals to invest in robotic endoscopy equipment, heightened public awareness of robot-assisted medical procedures, and the substantial presence of major market players in the region. Additionally, the market experienced growth due to the increasing number of clinical trials related to robot-assisted endoscopes. For example, in December 2022, the first patient was enrolled in the Extend URO clinical study for the Hugo robotic surgical assistance in the United States, as reported by Medtronic plc, a prominent global healthcare technology company.

Looking ahead, the Asia Pacific region is anticipated to register the highest CAGR during the forecast period. This regional demand is expected to be driven by factors such as increased disposable income, rising healthcare expenditures, and the prevalence of chronic illnesses. Furthermore, the growing adoption of robotic systems in healthcare facilities is projected to fuel the demand. Additionally, increased investment in cutting-edge medical technologies and procedures, including robotic-assisted endoscopies, has been spurred by the escalating healthcare spending in countries like China and India.

Major companies operating in Global Robot-assisted Endoscope Market are:

  • Asensus Surgical Inc
  • Intuitive Surgical Inc
  • Auris Health Inc
  • Johnson & Johnson
  • Brainlab AG
  • Medtronic PLC
  • Boston Scientific Corp
  • Stryker Corp

 

Download Free Sample Report

Customers can also request for 10% free customization on this report

 

“The global robot-assisted endoscope market is on the cusp of transformative change. The upcoming trends in telemedicine, AI integration, miniaturization, single-port and multi-arm systems, AR and VR technologies, global expansion, and patient-centric customization promise to redefine the landscape of robot-assisted endoscopy. These trends are set to not only enhance the capabilities of the technology but also improve patient outcomes, increase accessibility, and offer a higher degree of customization and precision in medical procedures. The future of robot-assisted endoscopy is both promising and dynamic, with exciting possibilities for the advancement of healthcare on a global scale,” said Mr. Karan Chechi, Research Director with TechSci Research, a research-based management consulting firm.

Global Robot-assisted Endoscope Market By End-use (Hospitals, Outpatient Facilities, Others), By Region, By Competition Forecast & Opportunities, 2018-2028F”, has evaluated the future growth potential of Global Robot-assisted Endoscope Market and provides statistics & information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in Global Robot-assisted Endoscope Market.

 

Contact Us-

TechSci Research LLC

420 Lexington Avenue, Suite 300,

New York, United States- 10170

M: +13322586602

Email: [email protected]

Website: www.techsciresearch.com

Relevant Reports

Robot-assisted Endoscope Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By End-use (Hospitals, Outpatient Facilities, Others), By Region, and By Competition

Healthcare | Jan, 2024

Technological advancements, improved diagnostic capabilities, and quicker recovery periods are factors driving the Global Robot-assisted Endoscope market in the forecast period 2024-2028.

Relevant News